Teva Pharmaceutical Industries Ltd (TEVA, Financial), Nielsen Holdings PLC (NLSN, Financial), Perrigo Co PLC (PRGO, Financial), and Kimco Realty Corp (KIM, Financial) have declined to their three-year lows.
Teva Pharmaceutical Industries Ltd (TEVA, Financial) Declined to $31.13
The prices of Teva Pharmaceutical Industries Ltd (TEVA, Financial) shares have declined to $31.13 on April 21, which is only 1.5% above the 3-year low of $30.66.
Teva Pharmaceutical Industries Ltd is an Israeli international pharmaceutical company that specializes in genetic drugs. Other business interests include active pharmaceutical ingredients and proprietary pharmaceuticals. It is the largest generic pharmaceutical drug manufacturer in the world and among the top 15 largest pharmaceutical companies worldwide.
Teva Pharmaceutical Industries Ltd has a market cap of $32.96 billion; its shares were traded around $31.13 with a P/E ratio of 518.84 and P/S ratio of 1.35. The trailing 12-month dividend yield of Teva Pharmaceutical Industries Ltd stocks is 4.36%. The forward dividend yield of Teva Pharmaceutical Industries Ltd stocks is 4.42%. Teva Pharmaceutical Industries Ltd had an annual average earnings growth of 7.40% over the past 10 years.
On April 20, Teva Pharmaceutical Industries announced the simultaneous launch of AirDuo RespiClick inhalation powder and its authorized generic for the treatment of asthma in patients aged 12 years and older who are uncontrolled on an inhaled corticosteroid. The product was approved by the United States Food and Drug Administration in January 2017 in three doses: 55/14 mcg, 113/14 mcg and 232/14 mcg administered as one inhalation twice daily.
Nielsen Holdings PLC (NLSN, Financial) Declined to $41.00
The prices of Nielsen Holdings PLC (NLSN, Financial) shares have declined to $41.00 on April 21, which is only 1.8% above the 3-year low of $40.28.
Nielsen Holdings PLC is an American international information, data, and measurement company that operates in over 100 countries and employs more than 44,000 people worldwide. Total revenues for the company were $6.2 billion in 2015.
Nielsen Holdings Plc has a market cap of $14.71 billion; its shares were traded around $41.00 with a P/E ratio of 29.49 and P/S ratio of 2.36. The trailing 12-month dividend yield of Nielsen Holdings Plc stocks is 3.03%. The forward dividend yield of Nielsen Holdings Plc stocks is 3.01%. Nielsen Holdings Plc had an annual average earnings growth of 11.20% over the past 5 years.
On April 19 Nielsen Holdings Plc announced that it has been named to Google’s Marketing Mix Model Partner program. As a preferred partner, Nielsen can collect Google advertising impression and spend data directly from Google in a standardized, granular, and accurate way. Collectively, this ensures that advertisers can measure the ROI of their digital investments with precision and confidently understand the drivers of ROI to improve returns.
Perrigo Co PLC (PRGO, Financial) Declined to $66.43
The prices of Perrigo Co PLC (PRGO, Financial) shares have declined to $66.43 on April 21, which is only 1.4% above the 3-year low of $65.47.
Perrigo Co PLC is an American multinational manufacturer of pharmaceuticals, specializing in the production and sale of over-the-counter medicine. The company manufactures and sells consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients in the United States, Australia, Europe, Indian, and Israel.
Perrigo Co Plc has a market cap of $9.47 billion; its shares were traded around $66.43 with and P/S ratio of 1.70. The trailing 12-month dividend yield of Perrigo Co Plc stocks is 0.90%. The forward dividend yield of Perrigo Co Plc stocks is 0.96%. Perrigo Co Plc had an annual average earnings growth of 21.50% over the past 5 years.
On March 27 Perrigo Co PLC announced that it has completed the divestiture of its rights to the royalty stream from global net sales of the multiple sclerosis drug Tysabri to RPI Finance Trust, an affiliate of Royalty Pharma. The transaction encompasses a total consideration of $2.2 billion and up to $650 million in royalties earned if global net sales of the drug Tysabri meet thresholds in 2018 and 2020.
Kimco Realty Corp (KIM, Financial) Declined to $22.23
The prices of Kimco Realty Corp (KIM, Financial) shares have declined to $22.23 on April 21, which is only 3.6% above the 3-year low of $21.43.
Kimco Realty Corp is an American real estate investment trust and North America’s largest publicly traded owner and operator of open-air shopping centers. As of 2016, the company owns interests in 524 shopping centers in the United States, comprising of 85 million square feet across 35 states and Puerto Rico.
Kimco Realty Corp has a market cap of $9.25 billion; its shares were traded around $22.23 with a P/E ratio of 27.79 and P/S ratio of 7.95. The trailing 12-month dividend yield of Kimco Realty Corp stocks is 4.71%. The forward dividend yield of Kimco Realty Corp stocks is 4.78%. Kimco Realty Corp had an annual average earnings growth of 5.40% over the past 5 years.
On April 6, Kimco Realty Corp announced its transaction activity for the first quarter of 2017. The company had two acquisitions of operating properties for the first quarter, totaling $43.1 million and a 90% ownership interest in a new mixed-use development project for $10 million. The two operating properties were Plaza Del Prado and Columbia Crossing, while the mixed-use development project was Lincoln Square located in Philadelphia.
Disclosure: I do not own stock in any of the companies mentioned in the article.
